Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 19, 2002

View Archived Issues

A novel COX-2 inhibitor may increase the antiproliferative effects of lovastatin in colon cancer

Somatostatin analogue TT-232 reported to be effective against inflammation and hyperalgesia

IST-FS-29 effective in murine tumor models, well tolerated after repeated doses

Resiniferatoxin: safe and effective for neurogenic and idiopathic bladder overactivity

Wild-type and lamivudine-resistant hepatitis B virus susceptible to MCC-478

Protein phosphatase-1 suppresses learning and memory and may mediate age-related cognitive decline

New erythromycin antibiotics in early development at Abbott

Servier researchers report three series of FTase inhibitors

Dual PDE3/PDE4 inhibitor attenuates inflammation and bronchoconstriction in ARDS

CRL-42796 prevents experimental carotid and coronary artery thrombosis

Use of fruit extracts containing momordin Ic in rheumatoid arthritis

KW-4490 advances to phase II as a potential asthma therapeutic

NeuroSearch interim report includes R&D update

Toagosei reveals newest antifungal agents

Angiogenesis inhibitors a focus of research at Kinetek

Schering-Plough presents new MCH antagonists for use in obesity

Analgesic alpha2-adrenoceptor agonists covered by Ortho-McNeil patent

Novel sustained-release hydrogel-based formulation of paclitaxel compared to Taxol

Altocor approved for additional indication

Amevive application to be reviewed within six months

Funding for EraGen rapid genetic diagnostic test for cystic fibrosis

New anticancer product candidate at Ariad

Cymbalta deemed approvable by FDA

Seasonale NDA accepted for review

EMEA grants orphan drug status to APT-070 in kidney transplantation

Primary efficacy endpoints reached in phase III Raptiva study

MX-8899 evaluated in new radiation-induced dermatitis trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...